ACTRN12605000283673招募中3 期
A 12-month Randomised, Placebo-controlled Trial of Testosterone Replacement Therapy and Lifestyle Modification Versus Lifestyle Modification Alone on Visceral Adiposity and Markers of Cardiovascular Risk in Obese Middle-Aged and Older Men
PHIMR0 个研究点目标入组 40 人开始时间: 2005年9月2日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 40 Years 至 70 Years（—）
- 性别
- Male
入选标准
- •BMI between 30-39.9 kg/m2 and WC equal to or greater than102cm, Serum total Testosterone <12nM.
排除标准
- •Smokers, Significant medical condition, Sleep Apnoea, Contra-indications to Testosterone therapy.
研究者
相似试验
进行中（未招募）
1 期
A 12-Week, Double-Blind, Placebo-Controlled Trial of LY2428757 in Patients with Type 2 Diabetes MellitusEUCTR2008-004207-63-DEEli Lilly and Company, Indianapolis300
进行中（未招募）
不适用
A 12-Week, Double-Blind, Placebo-Controlled Trial of LY2428757 in Patients with Type 2 Diabetes MellitusEUCTR2008-004207-63-GBEli Lilly and Company, Indianapolis300
进行中（未招募）
不适用
A 12-Week, Double-Blind, Placebo-Controlled Trial of LY2428757 in Patients with Type 2 Diabetes MellitusEUCTR2008-004207-63-ATEli Lilly and Company, Indianapolis300
已完成
2 期
A Study for Patients With Type 2 Diabetes MellitusCTRI/2009/091/000091Eli Lilly
招募中
不适用
Clinical Trial for the evaluation of the efficacy and safety of 7-MEGATM500 on the Skin wrinkle improvementDiseases of the skin and subcutaneous tissueKCT0004592Vitech90